Astrana Health Inc.
ASTH | NASDAQ
$33.55
-$0.81 (-2.36%)
At close: Sep 21, 2026, 4:00 PM ET
$33.95
+$0.40 (+1.18%)
Pre-market:
Sep 22, 2026, 5:57 AM ET
Market Data
Market Cap $1.66B
Enterprise Value $2.24B
Beta 0.91
Average Volume 550.29K
Shares Outstanding (Diluted) 49.78M
Shares Change YoY 0.62%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US03763A2078
Price Performance
Price Change 1M -14.4%
Price Change 3M -18.6%
Price Change 6M 37.0%
Price Change YTD 33.0%
Price Change 1Y 23.9%
Price Change 3Y 12.1%
Price Change 5Y -64.9%
1M CAGR (ann.) -6.2%
1Y CAGR (ann.) 12.6%
5Y CAGR (ann.) -17.8%
All-Time CAGR 7.5%
Valuation
PE Ratio 40.91
Forward PE 16.60
PEG Ratio 0.72
Forward PEG 0.99
PS Ratio 0.43
Forward PS 0.40
PB Ratio 2.00
P/FCF Ratio 10.50
P/Adj. FCF Ratio 15.43
P/OCF Ratio 9.37
EV/Sales 0.58
EV/EBIT 17.59
EV/EBITDA 12.82
EV/FCF 14.15
Earnings Yield 2.4%
FCF Yield 9.5%
Adj. FCF Yield 6.5%
Financial Health
Net Debt $535.71M
Total Debt $979.41M
Cash & Short-Term Investments $400.79M
Total Assets $2.28B
Current Ratio 1.23
Quick Ratio 1.23
Debt / Equity Ratio 1.18
Debt / EBITDA 5.60
Debt / FCF 6.18
OCF / Debt 0.18
Interest Coverage 1.49
Altman Z-Score 2.76
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 9.2%
Operating Profit Margin 2.6%
EBITDA Margin 4.5%
Net Profit Margin 1.1%
FCF Margin 4.1%
Adj. FCF Margin 2.8%
SBC / Revenue 1.3%
SBC Impact (per share) -32.0%
Returns
Return on Assets 1.8%
Return on Equity 5.1%
Return on Invested Capital 4.1%
Return on Capital Employed 6.5%
Return on Tangible Assets 3.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 43.7%
Revenue CAGR 5Y 85.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -8.2%
EPS CAGR 5Y 24.0%
EPS CAGR 10Y N/A
FCF CAGR 3Y 37.4%
FCF CAGR 5Y 62.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 57.3%
Revenue Growth Next 3Y 10.0%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $0.44
EPS Growth Est (next Q) 4300.0%
Revenue Est (next Q) $1.02B
Revenue Growth Est (next Q) 6.7%
Fair Value Estimates
Graham Number $15
Graham Upside -55.3%
Lynch Fair Value $19.66
Lynch Upside -41.4%
Price Target $52
Price Target Upside 55.0%
Cash Flow
Operating Cash Flow $175.93M
Free Cash Flow $158.44M
Adj. Free Cash Flow $107.78M
FCF Per Share $3.23
OCF Per Share $3.58
OCF/S Ratio 4.6%
Income Statement
Revenue $3.84B
Gross Profit $354.53M
Operating Income $100.46M
EBITDA $174.91M
Net Income $40.55M
EPS (Diluted) $0.82
Revenue / Employee $1.28M
Profit / Employee $13.52K
Employees 3,000
Add to Watchlist
Select watchlists to add or remove ASTH